EAU 2025

BIOTYPE at the EAU Congress 2025 – Advancing Precision Diagnostics for Bladder Cancer in Madrid!

Join us from 21 to 24 March 2025 at the 40th Annual Congress of the European Association of Urology (EAU) in Madrid, Spain!

At BIOTYPE, we are committed to driving innovation in bladder cancer diagnostics. Our MODAPLEX assay portfolio, which already enables the precise detection of FGFR3 mutations and FGFR2/3 gene fusions, will be expanded to include gene expression analysis on bladder samples. This will provide deeper insights for more personalized bladder cancer management.

Would you like to arrange a meeting with our experts at EAU 2025? Please contact Vanessa Grunwald, Tina Schubert, and Timm Zörgiebel via direct message for a face-to-face discussion on the latest advances in bladder cancer diagnostics.

We look forward to talking to you!